Endpoints News 2026-02-07 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Endpoints News 2026-02-06 Geoff McDonough's big plans for NodThera's NLRP3; Enhertu leader steps down at Daiichi
Endpoints News 2026-02-06 Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis
Endpoints News 2026-02-06 Illumina bets on healthcare after Trump administration's NIH funding disruptions
Illumina 2026-02-06 Illumina bets on healthcare customers after NIH funding disruptions - Endpoints News
Endpoints News 2026-02-05 #ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial